Evidence map›Paper›PMID 42370134›Full record

ArticleFrontiers in oncology2026

Postoperative radiotherapy-induced pulmonary leiomyosarcoma in breast cancer: a case report and literature review.

Dewei Zhang, Shihan Shi, Yang Wei, Jin Wei, Linwei Yang, Si Gui, Xuejian Wang, Liming Zhou, Yan Zhang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dewei Zhang *Department of Medical Imaging, Guihang 300 Hospital Affiliated to Zunyi Medical University, Guiyang, China.
Shihan Shi *Guizhou Medical University, Guiyang, China.
Yang WeiDepartment of Medical Imaging, Guihang 300 Hospital Affiliated to Zunyi Medical University, Guiyang, China.
Jin WeiDepartment of Medical Imaging, Guihang 300 Hospital Affiliated to Zunyi Medical University, Guiyang, China.
Linwei YangDepartment of Medical Imaging, Guihang 300 Hospital Affiliated to Zunyi Medical University, Guiyang, China.
Si GuiDepartment of Medical Imaging, Guihang 300 Hospital Affiliated to Zunyi Medical University, Guiyang, China.
Xuejian WangDepartment of Medical Imaging, Guihang 300 Hospital Affiliated to Zunyi Medical University, Guiyang, China.
Liming ZhouDepartment of Medical Imaging, Guihang 300 Hospital Affiliated to Zunyi Medical University, Guiyang, China.
Yan ZhangDepartment of Medical Imaging, Guihang 300 Hospital Affiliated to Zunyi Medical University, Guiyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation-induced sarcoma (RIS) is a rare and severe complication of radiotherapy following breast cancer surgery. It is characterized by a long latency period, high malignancy, limited clinical experience in diagnosis and treatment, and substantial individual variation in prognosis. This study reports a case of radiation-related pulmonary leiomyosarcoma that developed more than 20 years after radiotherapy for breast cancer. The tumor harbored a TP53 mutation and showed low PD-L1 expression. Imaging documented rapid tumor progression over a short interval, which rendered radical resection impossible and complicated efforts to improve quality of life. However, the patient attempted to receive multiple treatments-interventional therapy, chemotherapy, targeted therapy, and immunotherapy-but the response was poor, survival was under 10 months, and the patient ultimately died.

Indexed as

breast cancerimaging findingsleiomyosarcomaradiation-associated sarcomasradiotherapy

Identifiers

PMID42370134
PMCPMC13303022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.